Luminal type breast cancer (BrCa) cells invade into the surrounding tissues as collective strands, making them more metastatic than single cells. We have previously reported that the leading subpopulation of collective cells expressed high levels of CD44, which was associated with enhanced migratory and invasive potential of BrCa. It is crucial to elucidate how CD44 becomes enriched in leader cells and contributes to collective migration. In this study, we aimed to uncover the mechanisms responsible for CD44 upregulation in this context. First, we demonstrated that CD44 could facilitate dynamic lamellipodia formation by interacting with cytoskeletal proteins through its cytoplasmic domain. Then, we identified that a transcriptional regulator, Sin3a, was remarkably upregulated at the front edge of collectively migrating cells, exhibiting a correlation with enhanced CD44 expression. Notably, the knockdown of Sin3a effectively suppressed CD44 enrichment and lamellipodia outgrowth in leader cells, resulting in a significantly decreased cohesive movement of BrCa cells in vitro and in vivo. Our findings suggested that Sin3a was a novel regulator in CD44-facilitated lamellipodia formation and subsequent collective migration. This study elucidated the molecular mechanism underlying CD44 upregulation during collective migration of luminal-type BrCa cells, providing potential therapeutic targets to prevent cancer metastasis.
The transcriptional regulator Sin3a activates CD44 and promotes collective luminal breast cancer cell migration.
转录调节因子 Sin3a 激活 CD44 并促进管腔型乳腺癌细胞的集体迁移
阅读:6
作者:Qiu Yaqi, Luan Guangxin, Liu Yiwen, He Yiqing, Zhang Guoliang, Guo Qian, Yang Cuixia, Du Yan, Gao Feng
| 期刊: | Journal of Biological Chemistry | 影响因子: | 3.900 |
| 时间: | 2025 | 起止号: | 2025 Jun;301(6):110264 |
| doi: | 10.1016/j.jbc.2025.110264 | 靶点: | CD44 |
| 研究方向: | 细胞生物学 | 疾病类型: | 乳腺癌 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
